| CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
MINK1 |
MAP4K6, MINK1, MINK: Misshapen-like kinase 1 |
3.042 |
Evidence |
|
| SNX2 |
SNX2, TRG9: Sorting nexin-2 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
3.042 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
PTPRA |
IPI00032333 |
3.042 |
Evidence |
|
| PTPRA |
IPI00032333 |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
3.042 |
Evidence |
|
| RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
PRKCD |
PRKCD: Protein kinase C delta type |
3.042 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
GRB10 |
IPI00012752 |
3.042 |
Evidence |
|
| NTRK1 |
NTRK1, TRK: High affinity nerve growth factor receptor precursor |
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
3.042 |
Evidence |
|
| CSNK2A2 |
CSNK2A2, CK2A2: Casein kinase II subunit alpha' |
MIP |
MIP, AQP0: Lens fiber major intrinsic protein |
3.042 |
Evidence |
|
| MYL9 |
MYL9, MLC2, MRLC1, MYRL2: Myosin regulatory light chain 2, smooth muscle isoform |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
3.042 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
PARVA |
PARVA, MXRA2: Alpha-parvin |
3.04 |
Evidence |
|
| TIAL1 |
TIAL1: Nucleolysin TIAR |
PABPC3 |
PABPC3, PABP3, PABPL3: Polyadenylate-binding protein 3 |
3.037 |
Evidence |
|
| K-ALPHA-1 |
TUBA1A, TUBA3: Tubulin alpha-1A chain |
TUBB2A |
TUBB2A, TUBB2: Tubulin beta-2A chain |
3.037 |
Evidence |
|
| SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
PABPC3 |
PABPC3, PABP3, PABPL3: Polyadenylate-binding protein 3 |
3.037 |
Evidence |
|
| HIST1H2BK |
HIST1H2BK, H2BFT, HIRIP1: Histone H2B type 1-K |
HIST1H2BD |
HIST1H2BD, H2BFB, HIRIP2: Histone H2B type 1-D |
3.037 |
Evidence |
|
| H2BFS |
H2BFS: Histone H2B type F-S |
HIST1H2BD |
HIST1H2BD, H2BFB, HIRIP2: Histone H2B type 1-D |
3.037 |
Evidence |
|
| APOL1 |
APOL1, APOL: Apolipoprotein-L1 precursor |
F2 |
F2: Prothrombin precursor |
3.037 |
Evidence |
|
| NRAS |
HRAS, HRAS1: GTPase HRas precursor |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
3.037 |
Evidence |
|
| EIF4E |
EIF4E, EIF4EL1, EIF4F: Eukaryotic translation initiation factor 4E |
NEK1 |
NEK1, KIAA1901: Serine/threonine-protein kinase Nek1 |
3.035 |
Evidence |
|
| JUND |
JUND: Transcription factor jun-D |
PLA2G4A |
PLA2G4A, CPLA2, PLA2G4: Cytosolic phospholipase A2 |
3.035 |
Evidence |
|
| EIF4EBP1 |
EIF4EBP1: Eukaryotic translation initiation factor 4E-binding protein 1 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
3.035 |
Evidence |
|
| CKAP1 |
TBCB, CG22, CKAP1: Tubulin folding cofactor B |
HMGA1 |
HMGA1, HMGIY: High mobility group protein HMG-I/HMG-Y |
3.032 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
PILRA |
PILRA: Paired immunoglobulin-like type 2 receptor alpha precursor |
3.032 |
Evidence |
|
| ACTN3 |
ACTN3: Alpha-actinin-3 |
MYOZ2 |
MYOZ2, C4orf5: Myozenin-2 |
3.027 |
Evidence |
|
| EIF4E |
EIF4E, EIF4EL1, EIF4F: Eukaryotic translation initiation factor 4E |
MAP2K3 |
MAP2K3, MEK3, MKK3, PRKMK3: Dual specificity mitogen-activated protein kinase ki |
3.022 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
EFNA1 |
EFNA1, EPLG1, LERK1, TNFAIP4: Ephrin-A1 precursor |
3.022 |
Evidence |
|